Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis

British Journal of Dermatology

Volumn 134, Issue 6, 1996, Pages 1070-1078

  Perez, A ^a   Raab, R ^a   Chen, T C ^a   Turner, A ^a   Holick, M F ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSORIASIS;

EID: 0030000992     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07945.x     Document Type: Article

References (33)

1. 3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol 1988 19: 516-28.
2. 3 treatment in psoriasis vulgaris. Br J Dermatol 1983: 115: 421-9.
3. 3 analogue (MC903) in a double-blind study. Br J Dermatol 1988: 119: 223-30.
4. 3 analogue, 1 alpha, 24-dihydroxycholecalciferol. Br J Dermatol 1986: 115: 431-3.
5. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown serum free conditions. J Invest Dermatol 1986: 86: 709-14.
6. 3. Endocrinology 1983: 113: 1950-7.
7. 3. Med J Osaka Univ 1985: 35: 51-4.
8. DeLuca H. The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 1988: 2: 224-36.
9. Holick MF, Vitamin D: Biosynthesis metabolism and mode of action. In: Endocrinology (DeGroot LJ, Besser M, Burger HG, eds). Philadelphia: WB Saunders 1989: 902-26.
10. Fredricksson T, Pettersson U. Severe psoriasis: Oral therapy with a new retinoid. Dermatologica 1978: 157: 238-44.
11. Chen TC, Turner AK, Holick MF. Methods for the determination of the circulating concentrations of 25-hydroxyvitamin D. J Nutr Biochem 1990: 1: 315-19.
12. Chen TC, Turner AK, Holick MF. A method for the determination of the circulating concentrations of 1,25-dihydroxyvitamin D. J Nutr Biochem 1990: 1: 320-7.
13. Higashi A, Peters L. A rapid colorimetric method for the determination of inulin in plasm and urine. J Lab Clin Med 1950: 35: 475-82.
14. 3. Med J Osaka Univ 1985: 35: 51-4.
15. 3. A review of our experience. Arch Dermatol 1989: 125: 231-4.
16. 3 derivatives in the treatment of psoriasis vulgaris: a preliminary report. Mayo Clin Proc 1993: 68: 835-41.
17. 3, MC 903 and their analogues herald a new pharmacologic era for the treatment of psoriasis? Arch Dermatol 1989: 125: 1692-7.
18. Holick MF. Active vitamin D compounds and analogues: A new therapeutic era for dermatology in the 21st Century. Mayo Clin Prof 1993: 68: 925-7.
19. Curhan GC, Willet WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993: 328: 833-8.
20. Nordin, BEC. Vitamin-D analogues and renal function. Lancet 1978: ii: 1259-60.
21. Christiansen C, Rodbro P, Christenson MS et al. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet 1978: ii: 700-3.
22. 3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone mineral metabolism and kidney function. Clin Nephrol 1980: 13: 103-8.
23. Christiansen C, Rodbro P, Christensen MS et al. Is 1,25-dihydroxycholecalciferol harmful to renal function in patients with chronic renal failure? Clin Endocrinol 1981: 15: 229-36.
24. Bertoli M, Luisetto G, Ruffatti A et al. Renal function during calcitriol therapy in chronic renal failure. Clin Nephrol 1990: 33: 98-102.
25. Pitts RF. Physiology of the Kidney and Body Fluids. Chicago; Year Book Publishers, Inc:, 1968; 62-70.
26. Smith H. Clearances Involving Tubular Excretion: Endogenous Creatinine Chromogen Clearance in the Kidney: Structure and Function. New York: Oxford University Press, 1951: 190-4.
27. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982: 2: 337-46.
28. Molina E, Herrera J, Rodriguez-Iturbe B. The renal functional reserve in health and renal disease in school age childre. Kidney Int 1988: 34: 809-16.
29. 3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest 1986: 77: 312-14.
30. 3. Proc Natl Acad Sci USA 1483: 80: 5907-11.
31. 3 administration raises serum osteocalcin in patients with postmenopausal osteoporosis. J Clin Endocrinol Metab 1985: 60: 615-17.
32. Tilyard MW, Spears GFS, Thomson D, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992: 326: 357-62.
33. 3: A pilot study. Arthritis Rheum 1990: 33: 1723-7.